Outreach-ER: A Dementia Care Intervention Program

Sponsor
HealthPartners Institute (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05451693
Collaborator
(none)
30
2
12
15
1.3

Study Details

Study Description

Brief Summary

This is a feasibility/pilot, prospective cohort study to determine how to implement and refine Outreach-ER intervention for a larger clinical study. A key feature of Outreach-ER is to reach out to people living with dementia (PLWD) and their families following an emergency room visit or hospitalization. The outcome of this study will help in the overall goal of studying the impact of Outreach-ER in a larger clinical study and focus on outcomes relevant to PLWD and their care partners.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Outreach-ER

Study Design

Study Type:
Observational
Anticipated Enrollment :
30 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Outreach-ER: A Dementia Care Intervention Program
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2023
Anticipated Study Completion Date :
Sep 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Outreach-ER

Outreach-ER is a psychosocial intervention designed by dementia experts in the field of care partner interventions. The care plan will be personalized to the needs of the care partner/PLWD.

Behavioral: Outreach-ER
The intervention is similar to other care intervention/support programs such as REACH or New York University Caregiver Intervention (NYCUI). The Intervention is designed to be delivered over phone/virtual and in-home and will be conducted by Amplio, LLC consultants.

Outcome Measures

Primary Outcome Measures

  1. Number of attempted recruits for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Number of potential participants contacted. Higher number indicates higher number of attempts as recruitment.

  2. Recruitment rate for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Percentage of participants who enroll and consent [range: 0-100%]. Higher number indicates more feasibility.

  3. Participant rate for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Percentage of participants who start Outreach-ER program [range: 0-100%]. Higher number indicates more feasibility.

  4. Completion rate for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Percentage of participants who complete intervention (7 or more visits) [range: 0-100%]. Higher number indicates more feasibility.

  5. Session specific completion rate for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Percentage of participants who complete each intervention visit [range: 0-100%]. Higher number indicates more feasibility.

  6. Questionnaire specific response rate for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Percentage of participants who complete each questionnaire [range: 0-100%]. Higher number indicates more feasibility.

Secondary Outcome Measures

  1. Completeness of specific measures for feasibility and acceptability of Outreach-ER [through study completion, an average of 1.5 years]

    Percentage of care partners that respond to all of the items on each scale [range: 0-100%]. Higher number indicates more feasibility.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • PLWD with a recent Emergency department visit or admission at Regions Hospital

  • Diagnosis of dementia based on international classification of diseases (ICD) Codes in the medical record

  • Provides informed consent prior to participation

  • Must be able to read and speak English

  • PLWD Living at Home

  • Age >=18 years for PLWD and their care partner

Exclusion Criteria:
  • PLWD living in a nursing home/Long term care - Assisted living facility

  • Current involvement in another clinical research study/trial for care partners

  • PLWD medical record number (MRN) on the HealthPartners (HP) exclusion list

Contacts and Locations

Locations

Site City State Country Postal Code
1 Regions Hospital Saint Paul Minnesota United States 55101
2 HealthPartners Neuroscience Center Saint Paul Minnesota United States 55130

Sponsors and Collaborators

  • HealthPartners Institute

Investigators

  • Principal Investigator: Bhavani Kashyap, MBBS, PhD, HealthPartners Neuroscience Research
  • Principal Investigator: Leah R Hanson, PhD, HealthPartners Neuroscience Research

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
HealthPartners Institute
ClinicalTrials.gov Identifier:
NCT05451693
Other Study ID Numbers:
  • A22-086
First Posted:
Jul 11, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022